YJYing Jin

Ying Jin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ying Jin has a total of 14 co-authors. Here are the top co-authors by number of shared publications:

  • En-Zhi Yan

    Department of Pharmacology, Liaoning Medical University, Jinzhou 121001, China

    3 shared publications
  • Ying Fan

    Department of Pharmacology, Liaoning Medical University, Jinzhou 121001, China

    3 shared publications
  • Zhuo Liu

    Department of Pharmacology, Liaoning Medical University, Jinzhou 121001, China

    3 shared publications
  • Yan-Jie Zhao

    Department of Pharmacology, Liaoning Medical University, Jinzhou 121001, China

    2 shared publications
  • Zhi-Hong Zong

    Department of Biochemistry, China Medical University, Shengyang 110001, China

    2 shared publications
  • Hai-Juan Sui

    Department of Pharmacology, Liaoning Medical University, Jinzhou 121001, China

    1 shared publication

Latest Publications

  • Open Access

    Atorvastatin enhances neurite outgrowth in cortical neurons in vitro via up-regulating the Akt/mTOR and Akt/GSK-3β signaling pathways

    by Hai-Juan Sui, Yan Dong, Qi Ding, Wen-Hui Qu, Sheng-Xue Yu, Ying-Xin Jin

    Aim: Methods: Results: Conclusion:


  • Neuroprotective effect of sodium ferulate and signal transduction mechanisms in the aged rat hippocampus

    by Ying Jin, En-Zhi Yan, Xiao-Ming Li, Ying Fan, Yan-Jie Zhao, Zhuo Liu, Wan-Zhu Liu

    APS (Acta Pharmacologica Sinica), the top pharmacology research journal based in China, publishes original articles and reviews on all aspects of pharmacology and the related life sciences


  • Neuroprotection by sodium ferulate against glutamate-induced apoptosis is mediated by ERK and PI3 kinase pathways

    by Ying Jin, En-Zhi Yan, Ying Fan, Xiao-Li Guo, Yan-Jie Zhao, Zhi-Hong Zong, Zhuo Liu

    To investigate whether sodium ferulate (SF) can protect cortical neurons from glutamate-induced neurotoxicity and the mechanisms responsible for this protection. Cultured cortical neurons were incubated with 50 μmol/L glutamate for either 30 min or 24 h, with or without pre-incubation with SF (100, 200, and 500 μmol/L, respectively). LY294002, wortmannin, PD98059, and U0126 were added respectively to the cells 1 h prior to SF treatment. After incubation with glutamate for 24 h, neuronal apoptosis was quantified by scoring the percentage of cells with apoptotic nuclear morphology after Hoechst 33258 staining. After incubation with glutamate for either 30 min or 24 h, cellular extracts were prepared for Western blotting of active caspase-3, poly (ADP-ribose) polymerase (PARP), μ-calpain, Bcl-2, phospho-Akt, phosphorylated ribosomal protein S6 protein kinase (p70S6K), phospho-mitogen-activated protein kinase kinase (MEK1/2) and phosphorylated extracellular signal-regulated kinase (ERK) 1/2. SF reduced glutamate-evoked apoptotic morphology, active caspase-3 protein expression, and PARP cleavage and inhibited the glutamate-induced upregulation of the μ-calpain protein level. The inhibition of the phosphatidylinositol 3-kinase (PI3K) and the MEK/ERK1/2 pathways partly abrogated the protective effect of SF against glutamate-induced neuronal apoptosis. SF prevented the glutamate-induced decrease in the activity of the PI3K/Akt/p70S6K and the MEK/ERK1/2 pathways. Moreover, incubation of cortical neurons with SF for 30 min inhibited the reduction of the Bcl-2 expression induced by glutamate. The results indicate that PI3K/Akt/p70S6K and the MEK/ERK signaling pathways play important roles in the protective effect of SF against glutamate toxicity in cortical neurons.


  • Effects of sodium ferulate on amyloid-beta-induced MKK3/MKK6-p38 MAPK-Hsp27 signal pathway and apoptosis in rat hippocampus

    by Ying Jin, Ying Fan, En-Zhi Yan, Zhuo Liu, Zhi-Hong Zong, Zhi-Min Qi

    To observe the effects of sodium ferulate (SF) on amyloid beta (Aβ)1–40 induced p38 mitogen-activated protein kinase (MAPK) signal transduction pathway and the neuroprotective effects of SF. Rats were injected intracerebroventricularly with Aβ1–40. Six hours after injection, Western blotting was used to determine the expressions of phosphorylated mitogen-activated protein kinase kinase (MKK) 3/MKK6, phospho-p38 MAPK, interleukin (IL)-1β, phospho-MAPK activating protein kinase 2 (MAPKAPK-2), the 27 kDa heat shock protein (Hsp27), procaspase-9, -3, and -7 cleavage, and poly (ADP-ribose) polymerase (PARP) cleavage. Seven days after injection, Nissl staining was used to observe the morphological change in hippocampal CA1 regions. Intracerebroventricular injection of Aβ1–40 induced an increase in phosphorylated MKK3/MKK6 and p38 MAPK expressions in hippocampal tissue. These increases, in combination with enhanced interleukin (IL)-1β protein expression and reduced phospho-MAPKAPK2 and phospho-Hsp27 expression, mediate the Aβ-induced activation of cell death events as assessed by cleavage of procaspase-9, -3, and -7 and caspase-3 substrate PARP cleavage. Pretreatment with SF (100 mg/kg and 200 mg/kg daily, 3 weeks) significantly prevented Aβ1–40-induced increases in phosphorylated MKK3/MKK6 and p38 MAPK expression. The Aβ1–40-induced increase in IL-1β protein level was attenuated by pretreatment with SF. In addition, Aβ1–40-induced decreases in phosphorylated MAPKAPK2 and Hsp27 expression were abrogated by administration of SF. In parallel with these findings, Aβ1–40-induced changes in activation of caspase-9, caspase-7, and caspase-3 were inhibited by pretreatment with SF. SF prevents Aβ1–40-induced neurotoxicity through suppression of MKK3/MKK6-p38 MAPK activity and IL-1β expression and upregulation of phospho-Hsp27 expression.